E-LIB Suche - Ergebnisse für: Orroth, Kate K.

1

Redefining Disease Severity with Special Area Involvement a..:

Horner, Mary E. ; Orroth, Kate K. ; Ma, Junjie..
Dermatology and Therapy. 14 (2024) 1 - p. 187-199 , 2024

Link: https://doi.org/10.1007/..

2

Apremilast Adherence and Persistence in Patients with Psori..:

Das, Ashis K. ; Chang, Eunice ; Paydar, Caleb...
Dermatology and Therapy. 13 (2023) 9 - p. 1973-1984 , 2023

Link: https://doi.org/10.1007/..

3

Correction: Apremilast Adherence and Persistence in Patient..:

Das, Ashis K. ; Chang, Eunice ; Paydar, Caleb...
Dermatology and Therapy. 13 (2023) 9 - p. 1985-1985 , 2023

Link: https://doi.org/10.1007/..

4

How Labeling Warnings and Precautions May Impact the Propor..:

Langley, Richard ; Jardon, Shauna ; Montgomery, Jennifer...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 6 - p. s253 , 2023

Link: https://doi.org/10.25251..

5

Characteristics of patients with diabetes and a history of ..:

Hubbard, Demetria ; McKinley, Emily C. ; Colantonio, Lisandro D....
American Heart Journal Plus: Cardiology Research and Practice. 13 (2022) - p. 100121 , 2022

Link: https://doi.org/10.1016/..

6

The Projected Impact of Population-Wide Achievement of LDL ..:

McKinley, Emily C. ; Bittner, Vera A. ; Brown, Todd M....
Cardiovascular Drugs and Therapy. 37 (2021) 1 - p. 107-116 , 2021

Link: https://doi.org/10.1007/..

7

Risk for recurrent cardiovascular disease events among pati..:

Hubbard, Demetria ; Colantonio, Lisandro D. ; Rosenson, Robert S....
Cardiovascular Diabetology. 20 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

8

Evaluating a Simple Approach to Identify Adults Meeting the..:

Muntner, Paul ; Orroth, Kate K. ; Mues, Katherine E....
Cardiovascular Drugs and Therapy. 36 (2021) 3 - p. 475-481 , 2021

Link: https://doi.org/10.1007/..

9

Use of negative control outcomes to assess the comparabilit..:

Levintow, Sara N. ; Orroth, Kate K. ; Breskin, Alexander...
Pharmacoepidemiology and Drug Safety. 31 (2021) 4 - p. 383-392 , 2021

Link: https://doi.org/10.1002/..

10

Attempting to explain heterogeneous HIV epidemics in sub-Sa..:

Orroth, Kate K ; White, Richard G ; Freeman, Esther E...
Sexually Transmitted Infections. 87 (2011) 7 - p. 640-645 , 2011

Link: https://doi.org/10.1136/..

11

Population-level effect of potential HSV2 prophylactic vacc..:

Freeman, Esther E. ; White, Richard G. ; Bakker, Roel...
Vaccine. 27 (2009) 6 - p. 940-946 , 2009

Link: https://doi.org/10.1016/..

12

Quantifying HIV-1 transmission due to contaminated injectio..:

White, Richard G. ; Ben, S. Cooper ; Kedhar, Anusha...
Proceedings of the National Academy of Sciences. 104 (2007) 23 - p. 9794-9799 , 2007

Link: https://doi.org/10.1073/..

13

Quantifying HIV-1 Transmission due to Contaminated Injectio..:

White, Richard G. ; Cooper, Ben S. ; Kedhar, Anusha...
Proceedings of the National Academy of Sciences of the United States of America. 104 (2007) 23 - p. 9794-9799 , 2007

Link: https://www.jstor.org/st..

14

Author's Response: Response to Gray's Letter:

ORROTH, KATE K. ; WHITE, RICHARD G. ; HAYES, RICHARD J.
Sexually Transmitted Diseases. 34 (2007) 1 - p. 62 ff. , 2007

Link: https://www.jstor.org/st..

15

Empirical Observations Underestimate the Proportion of Huma..:

ORROTH, KATE K. ; WHITE, RICHARD G. ; KORENROMP, ELINE L....
Sexually Transmitted Diseases. 33 (2006) 9 - p. 536-544 , 2006

Link: https://www.jstor.org/st..